Nuwellis (NUWE) EBITDA Margin Growth (3y) (2016 - 2026)
Nuwellis (NUWE) EBITDA Margin Growth (3y) (2016 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 202.38 Bn | 196.77 Bn | 7.27 Bn | -201.00 |
| 2 | Stryker | 126.28 Bn | 122.80 Bn | 4.50 Bn | 586.00 |
| 3 | Medtronic | 119.30 Bn | 110.08 Bn | 6.41 Bn | 78.00 |
| 4 | Boston Scientific | 74.10 Bn | 73.56 Bn | 3.85 Bn | 736.00 |
| 5 | Edwards Lifesciences | 51.67 Bn | 47.42 Bn | 1.35 Bn | 887.00 |
| 6 | Dexcom | 35.07 Bn | 33.12 Bn | 830.00 Mn | 963.00 |
| 7 | GE HealthCare Technologies | 33.75 Bn | 31.65 Bn | 2.18 Bn | 212.00 |
| 8 | Koninklijke Philips | 26.20 Bn | 22.88 Bn | 4.55 Bn | 535.00 |
| 9 | Steris | 23.19 Bn | 22.70 Bn | 684.20 Mn | 244.00 |
| 10 | Nuwellis | 210,423.13 | -3.71 Mn | 1.50 Mn | 8,108.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 8,108.00 |
| Mar 31, 2026 | 13,033.00 |
| Dec 31, 2025 | 9,306.00 |
| Sep 30, 2025 | 6,818.00 |
| Jun 30, 2025 | 2,589.00 |
| Mar 31, 2025 | 6,857.00 |
| Dec 31, 2024 | 16,096.00 |
| Sep 30, 2024 | 21,866.00 |
| Jun 30, 2024 | 8,269.00 |
| Mar 31, 2024 | 1,632.00 |
| Dec 31, 2023 | 6,879.00 |
| Sep 30, 2023 | 9,240.00 |
| Jun 30, 2023 | -3,161.00 |
| Mar 31, 2023 | -4,024.00 |
| Dec 31, 2022 | 13,139.00 |
| Sep 30, 2022 | 17,015.00 |
| Jun 30, 2022 | 6,969.00 |
| Mar 31, 2022 | 15,961.00 |
| Dec 31, 2021 | 1,996.00 |
| Sep 30, 2021 | 2,843.00 |